AI brief of an SEC Form 8-K · West Pharmaceutical Services (WST)

West Pharmaceutical discloses material cyberattack that disrupted global operations

Negative Impact 5 of 5 other Written later

West Pharmaceutical Services said on May 7, 2026 that it had determined it experienced a material cyberattack, in which certain data was exfiltrated and certain systems were encrypted. The company took systems offline globally after detecting an intrusion on May 4, 2026, and says the incident has temporarily disrupted its business operations worldwide; the full restoration timeline has not been finalized and the financial impact has not been determined.

Key points

  • Intrusion first detected May 4, 2026; the company determined on May 7, 2026 that it was a material cyberattack
  • Certain data was exfiltrated and certain systems were encrypted; the investigation into the scope, including the data affected, is ongoing
  • Core enterprise systems have been restored, and shipping, receiving and manufacturing have restarted at some sites, with remaining sites in process
  • Impact on financial condition and results of operations has not been determined; law enforcement was notified and Palo Alto Networks' Unit 42 was engaged

The filing

CompanyWest Pharmaceutical Services (WST)
Form8-K, current report
Filed with the SECMay 11, 2026, 5:06 PM ET
Accession number0000105770-26-000068

Items reported: 1.05 Material Cybersecurity Incident7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.